PROQR THERAPEUTICS NV
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About PRQR
ProQR Therapeutics N.V. is a biotechnology company based in the Netherlands. The Company is engaged in the discovery and development of ribonucleic Acid (RNA)-based therapeutics for the treatment of severe genetic disorders. Main purpose of the Company is advancement of its Axiomer RNA-editing platform technology. That technology uses a cell’s own editing machinery called ADAR to make specific single nucleotide edits in RNA to reverse a mutation or modulate protein expression and could potentially yield a new class of medicines for both rare and prevalent diseases with unaddressed needs. The Company operates research pipeline that contains of RNA Therapy and AX-0810 Cholestatic Diseases (NTCP).
Find out what a historical investment in PROQR THERAPEUTICS NV would be worth today using our PRQR stock calculator.
$223.33M
-
0.00%
59
$2.15
$1.96
$0.00
$3.71
$1.07
Ready to start your investing journey with Stake?
Open an accountPRQR FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in PRQR
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PRQR
on Stake
Buy PRQR from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of PRQR from only US$10 with fractional shares
